| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
101,390,000 |
| Market
Cap: |
1.62(B) |
| Last
Volume: |
668,805 |
Avg
Vol: |
667,002 |
| 52
Week Range: |
$12.32 - $16.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Innoviva is a company with a portfolio of royalties and other healthcare assets. Co.'s royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and TRELEGY® ELLIPTA®. Co. is entitled to royalty payments made by GSK under its agreements that assigned to Theravance Respiratory Company, LLC (TRC), including TRELEGY® ELLIPTA® and any other product or combination of products that may be discovered or developed in the future under the Long-Acting Beta2 Agonist Collaboration Agreement and the Strategic Alliance Agreement with GSK, which have been assigned to TRC other than RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
664,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$8,468,005 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
12 |
| Total Shares Sold |
0 |
0 |
10,994 |
10,994 |
| Total Sell Value |
$0 |
$0 |
$153,810 |
$153,810 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brinkley David L |
Sr. VP Commercial Development |
• – – |
2005-09-07 |
4 |
OE |
$3.10 |
$392,934 |
D/D |
59,000 |
59,000 |
|
- |
|
| Levine Arnold J |
Director |
– • – |
2005-09-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
66,967 |
|
- |
|
| Whitesides George M |
Director |
– • – |
2005-07-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
23,230 |
170,318 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2005-04-04 |
4/A |
A |
$0.00 |
$0 |
I/I |
1,976 |
59,020 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2005-04-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,915 |
58,926 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2005-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,354 |
26,092 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2005-04-01 |
4/A |
A |
$0.00 |
$0 |
I/I |
1,103 |
58,917 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2005-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,070 |
58,884 |
|
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2005-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,609 |
19,738 |
|
- |
|
| Aguiar Michael W |
Sr VP, Chief Financial Officer |
• – – |
2005-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Sturmer A Gregory |
Vice President Finance |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$4,640 |
I/I |
290 |
290 |
1.91 |
- |
|
| Glick Marty |
Executive VP, Finance and CFO |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$32,000 |
D/D |
2,000 |
267,805 |
2.74 |
- |
|
| Humphrey Patrick Pa |
Executive VP Research |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$176,000 |
I/I |
11,000 |
11,000 |
1.99 |
- |
|
| Shafer Bradford J |
Sr VP, Gen. Counsel, Secretary |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$132,000 |
I/I |
8,250 |
2,750 |
1.99 |
- |
|
| Shafer Bradford J |
Sr VP, Gen. Counsel, Secretary |
• – – |
2004-10-05 |
4 |
B |
$16.00 |
$44,000 |
D/D |
2,750 |
230,974 |
2.74 |
- |
|
| Drazan Jeffrey M |
Director |
– • – |
2004-10-04 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,860,456 |
|
- |
|
| Baker Julian |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
33,839 |
|
- |
|
| Kitt Michael |
Sr. Vice President Development |
• – – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,354 |
|
- |
|
| Levine Arnold J |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,967 |
|
- |
|
| Loewenthal Ronn |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
598,776 |
|
- |
|
| Mullen Michael |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,007,168 |
|
- |
|
| Whitesides George M |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
193,548 |
|
- |
|
| Whitesides George M |
Director |
– • – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
589,028 |
|
- |
|
| Sturmer A Gregory |
Vice President FinanceOfficer |
• – – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,870 |
|
- |
|
| Sturmer A Gregory |
Vice President FinanceOfficer |
• – – |
2004-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
89,677 |
|
- |
|
710 Records found
|
|
Page 28 of 29 |
|
|
0.10 (0.63%) 
